Release of Gastric Inhibitory Polypeptide (GIP) by Intraduodenal Acidification in Rats and Humans and Abolishment of the Incretin Effect of Acid by GIP-Antiserum in Rats
- 1 March 1979
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 76 (3) , 515-523
- https://doi.org/10.1016/s0016-5085(79)80219-x
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Effect of secretin on basal- and glucose-stimulated insulin secretion in manDiabetologia, 1978
- Serum Gastric Inhibitory Polypeptide (GIP) in Duodenal Ulcer Disease: Relationship to Glucose Tolerance, Insulin, and Gastrin ReleaseScandinavian Journal of Gastroenterology, 1978
- Release of Vasoactive Intestinal Polypeptide (VIP) by Intraduodenal StimuliScandinavian Journal of Gastroenterology, 1977
- Is gastrin a major determinant of basal lower esophageal sphincter pressure? A double-blind controlled study using high titer gastrin antiserum.Journal of Clinical Investigation, 1976
- Effectiveness of the intestinal polypeptides, IRP, GIP, VIP and motilin on insulin release in the ratDiabetologia, 1974
- Effects of pancreozymin and secretin on insulin release and the role of the exocrine pancreasDiabetologia, 1974
- Studies of secretin-stimulated insulin responses in manJournal of Clinical Investigation, 1972
- The Genesis of Lower Esophageal Sphincter Pressure: Its Identification through the Use of Gastrin AntiserumJournal of Clinical Investigation, 1972
- Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in manJournal of Clinical Investigation, 1969
- Über die radioimmunologische Bestimmung von Insulin im BlutKlinische Wochenschrift, 1965